Cargando…
National survey on total-body irradiation prior to reduced-intensity stem cell transplantation in Japan: The Japanese Radiation Oncology Study Group
Reduced-intensity stem cell transplantation (RIST) minimizes the adverse effects of traditional hematopoietic stem cell transplantation, and low-dose total-body irradiation (TBI) is administered over a short period prior to RIST (TBI–RIST). Different institutes adopt different approaches for the adm...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6805977/ https://www.ncbi.nlm.nih.gov/pubmed/31125077 http://dx.doi.org/10.1093/jrr/rrz028 |
_version_ | 1783461521118986240 |
---|---|
author | Kawaguchi, Hiroki Soejima, Toshinori Ishibashi, Naoya Akiba, Takeshi Hasegawa, Masatoshi Isobe, Kouichi Ito, Hitoshi Imai, Michiko Ejima, Yasuo Hata, Masaharu Sasai, Keisuke Shimoda, Emiko Oguchi, Masahiko Akimoto, Tetsuo |
author_facet | Kawaguchi, Hiroki Soejima, Toshinori Ishibashi, Naoya Akiba, Takeshi Hasegawa, Masatoshi Isobe, Kouichi Ito, Hitoshi Imai, Michiko Ejima, Yasuo Hata, Masaharu Sasai, Keisuke Shimoda, Emiko Oguchi, Masahiko Akimoto, Tetsuo |
author_sort | Kawaguchi, Hiroki |
collection | PubMed |
description | Reduced-intensity stem cell transplantation (RIST) minimizes the adverse effects of traditional hematopoietic stem cell transplantation, and low-dose total-body irradiation (TBI) is administered over a short period prior to RIST (TBI–RIST). Different institutes adopt different approaches for the administration of TBI–RIST, and since no study had previously investigated this issue, a survey of the TBI schedules in Japan was conducted. In October 2015, the Japanese Radiation Oncology Study Group initiated a national survey of TBI–RIST procedures conducted between 2010 and 2014. Of 186 institutions performing TBI, 90 (48%) responded to the survey, 78 of which performed TBI–RIST. Of 2488 patients who underwent TBI for malignant disease at these institutions, 1412 (56.8%) patients were treated for leukemia, 477 (19.2%) for malignant lymphoma, 453 (18.2) for myelodysplastic syndrome, 44 (1.8%) for multiple myeloma, and 102 (4.1%) for other malignant diseases. Further, 206 (52.0%) of 396 patients (a high proportion of patients) who underwent TBI for benign disease had aplastic anemia. The TBI–RIST equipment and treatment methods were similar to those used for myeloablative regimens. Routinely shielded organs included the lungs (43.6%), eyes (50.0%) and kidneys (10.2%). The ovaries (14.1%), thyroid (6.4%) and testicles (16.7%) were also frequently shielded, possibly reflecting an emphasis on shielding reproductive organs in children. TBI–RIST was performed more frequently than myeloablative conditioning in patients with benign disease. Genital and thyroid shielding were applied more frequently in patients treated with TBI–RIST than in patients treated with myeloablative conditioning. In conclusion, this study indicates the status of TBI–RIST in Japan and can assist future efforts to standardize TBI–RIST treatment methods and to design a future multicenter collaborative research study. |
format | Online Article Text |
id | pubmed-6805977 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-68059772019-10-28 National survey on total-body irradiation prior to reduced-intensity stem cell transplantation in Japan: The Japanese Radiation Oncology Study Group Kawaguchi, Hiroki Soejima, Toshinori Ishibashi, Naoya Akiba, Takeshi Hasegawa, Masatoshi Isobe, Kouichi Ito, Hitoshi Imai, Michiko Ejima, Yasuo Hata, Masaharu Sasai, Keisuke Shimoda, Emiko Oguchi, Masahiko Akimoto, Tetsuo J Radiat Res Regular Papers Reduced-intensity stem cell transplantation (RIST) minimizes the adverse effects of traditional hematopoietic stem cell transplantation, and low-dose total-body irradiation (TBI) is administered over a short period prior to RIST (TBI–RIST). Different institutes adopt different approaches for the administration of TBI–RIST, and since no study had previously investigated this issue, a survey of the TBI schedules in Japan was conducted. In October 2015, the Japanese Radiation Oncology Study Group initiated a national survey of TBI–RIST procedures conducted between 2010 and 2014. Of 186 institutions performing TBI, 90 (48%) responded to the survey, 78 of which performed TBI–RIST. Of 2488 patients who underwent TBI for malignant disease at these institutions, 1412 (56.8%) patients were treated for leukemia, 477 (19.2%) for malignant lymphoma, 453 (18.2) for myelodysplastic syndrome, 44 (1.8%) for multiple myeloma, and 102 (4.1%) for other malignant diseases. Further, 206 (52.0%) of 396 patients (a high proportion of patients) who underwent TBI for benign disease had aplastic anemia. The TBI–RIST equipment and treatment methods were similar to those used for myeloablative regimens. Routinely shielded organs included the lungs (43.6%), eyes (50.0%) and kidneys (10.2%). The ovaries (14.1%), thyroid (6.4%) and testicles (16.7%) were also frequently shielded, possibly reflecting an emphasis on shielding reproductive organs in children. TBI–RIST was performed more frequently than myeloablative conditioning in patients with benign disease. Genital and thyroid shielding were applied more frequently in patients treated with TBI–RIST than in patients treated with myeloablative conditioning. In conclusion, this study indicates the status of TBI–RIST in Japan and can assist future efforts to standardize TBI–RIST treatment methods and to design a future multicenter collaborative research study. Oxford University Press 2019-10 2019-05-24 /pmc/articles/PMC6805977/ /pubmed/31125077 http://dx.doi.org/10.1093/jrr/rrz028 Text en © The Author(s) 2019. Published by Oxford University Press on behalf of The Japan Radiation Research Society and Japanese Society for Radiation Oncology. http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Regular Papers Kawaguchi, Hiroki Soejima, Toshinori Ishibashi, Naoya Akiba, Takeshi Hasegawa, Masatoshi Isobe, Kouichi Ito, Hitoshi Imai, Michiko Ejima, Yasuo Hata, Masaharu Sasai, Keisuke Shimoda, Emiko Oguchi, Masahiko Akimoto, Tetsuo National survey on total-body irradiation prior to reduced-intensity stem cell transplantation in Japan: The Japanese Radiation Oncology Study Group |
title | National survey on total-body irradiation prior to reduced-intensity stem cell transplantation in Japan: The Japanese Radiation Oncology Study Group |
title_full | National survey on total-body irradiation prior to reduced-intensity stem cell transplantation in Japan: The Japanese Radiation Oncology Study Group |
title_fullStr | National survey on total-body irradiation prior to reduced-intensity stem cell transplantation in Japan: The Japanese Radiation Oncology Study Group |
title_full_unstemmed | National survey on total-body irradiation prior to reduced-intensity stem cell transplantation in Japan: The Japanese Radiation Oncology Study Group |
title_short | National survey on total-body irradiation prior to reduced-intensity stem cell transplantation in Japan: The Japanese Radiation Oncology Study Group |
title_sort | national survey on total-body irradiation prior to reduced-intensity stem cell transplantation in japan: the japanese radiation oncology study group |
topic | Regular Papers |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6805977/ https://www.ncbi.nlm.nih.gov/pubmed/31125077 http://dx.doi.org/10.1093/jrr/rrz028 |
work_keys_str_mv | AT kawaguchihiroki nationalsurveyontotalbodyirradiationpriortoreducedintensitystemcelltransplantationinjapanthejapaneseradiationoncologystudygroup AT soejimatoshinori nationalsurveyontotalbodyirradiationpriortoreducedintensitystemcelltransplantationinjapanthejapaneseradiationoncologystudygroup AT ishibashinaoya nationalsurveyontotalbodyirradiationpriortoreducedintensitystemcelltransplantationinjapanthejapaneseradiationoncologystudygroup AT akibatakeshi nationalsurveyontotalbodyirradiationpriortoreducedintensitystemcelltransplantationinjapanthejapaneseradiationoncologystudygroup AT hasegawamasatoshi nationalsurveyontotalbodyirradiationpriortoreducedintensitystemcelltransplantationinjapanthejapaneseradiationoncologystudygroup AT isobekouichi nationalsurveyontotalbodyirradiationpriortoreducedintensitystemcelltransplantationinjapanthejapaneseradiationoncologystudygroup AT itohitoshi nationalsurveyontotalbodyirradiationpriortoreducedintensitystemcelltransplantationinjapanthejapaneseradiationoncologystudygroup AT imaimichiko nationalsurveyontotalbodyirradiationpriortoreducedintensitystemcelltransplantationinjapanthejapaneseradiationoncologystudygroup AT ejimayasuo nationalsurveyontotalbodyirradiationpriortoreducedintensitystemcelltransplantationinjapanthejapaneseradiationoncologystudygroup AT hatamasaharu nationalsurveyontotalbodyirradiationpriortoreducedintensitystemcelltransplantationinjapanthejapaneseradiationoncologystudygroup AT sasaikeisuke nationalsurveyontotalbodyirradiationpriortoreducedintensitystemcelltransplantationinjapanthejapaneseradiationoncologystudygroup AT shimodaemiko nationalsurveyontotalbodyirradiationpriortoreducedintensitystemcelltransplantationinjapanthejapaneseradiationoncologystudygroup AT oguchimasahiko nationalsurveyontotalbodyirradiationpriortoreducedintensitystemcelltransplantationinjapanthejapaneseradiationoncologystudygroup AT akimototetsuo nationalsurveyontotalbodyirradiationpriortoreducedintensitystemcelltransplantationinjapanthejapaneseradiationoncologystudygroup |